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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death around the world; however, many CVD
events could be prevented if we focused on modification of the main risk factors.
Increased salt consumption is estimated to have caused millions of deaths, mostly related to CVD, particularly
stroke, which is the leading cause of death in Portugal.
In our study, we aim to assess trends in the proportion of high blood pressure (HBP) in Acute Coronary Syndrome
(ACS) patients as well as the trends in stroke and ACS in Portugal, especially after a set of public health initiatives
were implemented to reduce salt intake.
Methods: The monthly proportion of ACS patients presenting with previously diagnosed HBP and the monthly rate of
CVD admissions into public hospitals in Portugal were calculated. CVD rates were stratified into ACS rate and stroke rates.
Data were stratified by demographics variables. An interrupted time-series model was used to assess changes over time.
Results: Breakpoint analysis revealed an estimated breakpoint around the year 2013 for the proportion of HBP patients,
the following year there was a decreasing trend, however it was not significant. Analyses showed the trend before
2013 was increasing and started to decrease after this year. This decreased in proportion of HBP patients can be
translated into a reduction of 555 people per year presenting with HBP in the ACS population.
We analysed trends for ACS and stroke and tested the significance for a breakpoint in the year 2013. Although none of
the remaining trends were significant for ACS crude rates and stroke crude rate, a decreasing trend was observed.
Conclusions: This research provides an indication about the impact a population-wide approach to CVD risk factors
has on CVD trends themselves. Our results suggest that population-wide approaches can have an impact on the
prevention and improvement of CVD control, reducing the number of CVD events, and eventually reducing premature
death by CVD. As more restrictions on salt intake are being planned in Portugal in the next years, it is highly relevant to
assess what is the current panorama and what further reductions we can expect.
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Background
Cardiovascular disease (CVD) is the leading cause of death
around the world [1]. An estimated 4 million people in
Europe die by CVD annually [2]. However, many of the
CVD events could be prevented if we focused on modifi-
cation of the main risk factors [3].
In 2010, high blood pressure (HBP) was the leading risk
factor contributing to global disease burden, accounting
for more than 15% of all health loss in adults [4], and
responsible for 62% of all strokes and 49% of ACS events
[5]. Although sodium is an essential nutrient necessary for
maintenance of plasma volume, acid-base balance, trans-
mission of nerve impulses, and normal cell function [6],
current salt consumption is much greater than needed for
survival, creating an overload on the metabolic system [7].
This overload can increase blood pressure (BP) [8].
Increased salt consumption is estimated to have caused
millions of deaths, mostly related to CVD, particularly
stroke, which is the leading cause of death in Portugal [9],
being one of the countries with the highest mortality rates
by stroke among the Western countries [10]. The high
prevalence of HBP is pointed to as one of the main reasons.
Implementing both population-wide and high-risk ap-
proaches to reduce blood pressure seems almost inevitable
due to the large burden of HBP [11, 12]. Even small reduc-
tions of HBP prevalence in the population could lead to
great health gains. Knowing the importance of these
approaches, the World Health Organization (WHO) created
a set of recommendations to reduce dietary salt to 5 g/day,
in order to prevent chronic disease and improve health [13].
In the European Union, 26 out of the 53 Member States, in-
cluding Portugal, implemented operational salt reduction
policies including laws aiming to reduce salt intake. Recent
reports have shown that salt consumption in Portugal has
been declining in recent decades to a minimum of 7.3 g/day
in 2016 [14]. Prospective studies have shown that reducing
salt intake can lead to reductions in blood pressure and,
eventually, to a reduction in CVD events [15].
By 2010 a set of public health initiatives were imple-
mented in Portugal, namely a reduction in salt added to
bread and mandatory salt labelling in pre-packed food. As
these initiatives are meant to reduce salt intake we hypoth-
esized that it could lead to a reduction in the proportion of
HBP and CVD, namely ACS and stroke. Therefore in our
study, we aim to assess the trends in the proportion of
HBP in ACS patients, as well as the trends in stroke and
ACS in the country, before and after these initiatives were
applied. For the sake of clarity in our study we refer as salt
for all sodium data.
Methods
Study population
Two population sets were used in this study. Approval
to access data was obtained previously. For both sets
of data, participants included in the study were over
20 years old.
First population dataset
The National Registry of Acute Coronary Syndrome
(NRACS) [16]. All data from 2002 to 2015 were extracted
for our study. This dataset was used to obtain the propor-
tion of ACS patients previously diagnosed with HBP. This
register collects information for ACS only, not just for risk
factors but also demographics.
This dataset has the advantage of being integrated into
the Euro Heart Survey platform and, consequently, uses
the Cardiology Audit and Registration Data Standards
(CARDS) system. This system ensures that credible and
comparable information is collected in several European
countries over time as they use standardised information,
both in terms of the definition and coding of variables,
and in the form of measurement and collection of data.
As this data is validated and standardised, it can be
applied to and used to validate analyses in other larger
populations, thus being able to obtain more robust
results [17]. HBP in this dataset was defined as previously
diagnosed by a physician, or known blood pressure >
140 mmHg systolic or > 90 mmHg diastolic on two or
more occasions.
Second population dataset
The National database that collects data from all admis-
sions into Portuguese public hospitals (Mainland Portugal).
Data from 2002 to 2016 were extracted for our study. This
database uses the Diagnosis Related Group (DRG) system
holding data on primary diagnosis and some demographic
variables, such as sex and age, as well as the geographic
region of admission [18]. DRG codes for ischemic and
haemorrhagic stroke were included in the analysis
(ICD 9th codes for stroke: 43301, 43321, 43311, 43331,
43391, 43401, 43411, 43491, 431, 432, 4320, 4321,
4329, and 43381) as well as codes for ACS (ICD 9th
codes: 410.00–410.xx to identify admissions diagnosed
as Acute Myocardial Infarction and code 4130 to identify
unstable angina).
The two datasets were analysed separately as there is
no possible method to identify the participants in the
dataset, thus the same participant can in fact be regis-
tered in both datasets, however as the outcomes stud-
ied are independent from each other we do not expect
this fact to influence on the validity of the analysis.
Similarly the fact that the two datasets used in our
study are carefully monitored by the Portuguese Society
of Cardiology, in the case of the NRACS, and the
Directorate of General Health, in the case of the DRG
data, ensures the validity of these data.
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Statistical analysis
Two main outcomes were analysed in our study, the
monthly proportion of ACS patients presenting with
previously diagnosed HBP and the monthly rate of CVD
admission into public hospitals in the country. CVD
rates were stratified into ACS rate and stroke rates.
The proportion of ACS patients with HBP was obtained
by dividing the number of monthly HBP diagnoses by the
total ACS patients registered for month.
We applied an interrupted time series design, imple-
menting a segmented multiple linear regression model, in
which the response variable was the monthly the propor-
tion of ACS patients with HBP. These models are useful
when the relationship between the response and the inde-
pendent variables are piecewise linear, namely represented
by two or more straight lines connected at unknown
values, which are usually referred to as breakpoints. In our
case, the breakpoint would be expected for any given year
where there was a change in the trend of the proportion
of patients with HBP.
R “segmented” package was used to determine the
presence of any breakpoints in the trends found.
Crude event rates for ACS and stroke (per 100,000
adults) were computed for each month, using the popula-
tion of the country, restricted to the population resident
in mainland Portugal, with ages over 20 years as the
denominator. Crude rates were calculated as the number
of events, for each outcome separately, divided by the
Portuguese population for that month.
As the effect of this type of population wide approaches
might not be immediate [19, 20], taking some time to
show effects in the population, we used the estimated
breakpoint from the monthly proportion of ACS patients
with HBP as a proxy for the effect of the estimated break-
point in CVD trends.
The impact of the breakpoint estimated on the CVD
trends, was assessed through a multiple linear regression
model using standard methods for interrupted time series.
We included one dichotomous variable that accounted
for the main effect on hospital admissions of the estimated
breakpoint for the proportion of HBP patients and an
interaction between the breakpoint estimated and time, to
evaluate changes over time following the breakpoint.
This model was implemented in order to test whether
there was a significant change in the number of events,
and if there was any change in the proportion of HBP
patients was observed.
A month indicator covariable was introduced to adjust
for seasonality in the outcomes admissions.
All analyses were stratified by sex and age. Age was
grouped into two categories < 65 and ≥ 65 years old.
Autocorrelation between month estimates was incorpo-
rated adequately into the model, with the presence of short
term autocorrelation applying a first order autoregressive -
AR (1) - structure to the residuals. Models were fitted in R
version 2.3.2 software.
Statistical significance was assessed through p-values,
assuming < 5% as significant and 95% confidence intervals
(CI) were calculated for each of the regression coefficients.
Results
A total of 43,271 ACS events were registered in the
NRACS over the last 14 years. The proportion of males
presenting with ACS has been consistently higher than
women, with around 69% of ACS events occurring in
males. Mean age through the years of study has also
been fairly steady, ranging from 65 to 66 years old
(Table 1). Male/female ratio for HBP patients (Fig. 1)
has also remained fairly steady through the years in the
ACS population.
The proportions of patients with HBP ranged from a
minimum proportion of 50.0% to a maximum of 79.2%.
Breakpoint analysis revealed an estimated breakpoint
around the year 2013 for the proportion of HBP patients
(Fig. 2), the year after there is a decreasing trend, however
it was not significant (p-value = 0.832). Analyses showed
the trend before 2013 was, in fact, increasing and started
to decrease after this year (βbefore = 0.009, CI: 0.007, 0.011;
βafter = − 0.003, CI: -0.037, 0.0302). Although zero is
present in the CI for the slope after 2013, the change
between both slopes (before and after 2013) is negative
with a decrease of − 0.012 in the monthly proportion.
Thus, the decrease estimated after 2013 is higher than
the increase estimated before 2013. This decrease in
proportion can be translated into a reduction of 555 people
per year presenting with HBP in the ACS population
(Table 2).
Figure 3 displays the frequency of ACS and stroke
admissions from 2002 to 2016. A total of 115 public
hospitals from mainland Portugal registered ACS ad-
missions from 2002 to 2016 and 122 registered stroke
admissions. A maximum age of 99 years old was found
in the database and the majority of admissions were for
both ACS and stroke.
We analysed trends for ACS and stroke and tested the
significance for a breakpoint in the year 2013.
Table 1 Demographic characterization of the data analysed
ACS (DRG data) Stroke (DRG data) HBP in ACS patients
(NRACS data)
Before regulation
Female % 26,00% 49,43% 35,33%
Age≥ 65% 37,93% 77,15% 65,38%
After regulation
Female % 26,36% 49,61% 32,67%
Age≥ 65% 37,85% 78,26% 64,29%
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Although none of the remaining trends were significant
(Table 2) for ACS crude rates (β = − 0.057, CI: - 0.154,
0.039) and stroke crude rate (β = − 0.049, CI: -0.128,
0.029), a decreasing trend can be observed.
When further stratified data by sex and age, although
no significant trends were observed, a decreasing trend for
ACS was found in women but not in men. The largest
decrease was found for people over 65 years old for
both outcomes. Nevertheless, all these results should be
interpreted with caution as none of the coefficients
were significant (p-values > 5%), and zero was always
included in the confidence interval.
The seasonal pattern observed for ACS and stroke was
consistent with that reported elsewhere [21], with higher
rates of admission over winter, and lower rates during
the summer (Fig. 3).
Discussion
Our results showed increasing trends in the proportion
of HBP comorbidity in the ACS population until 2013,
the following years the trends appear to decrease. This
year was used as a breakpoint to test for differences in
trends for ACS and stroke. Decreasing trends for both
outcomes were also found, but were not significant.
Although our results were not statistically significant,
and thus must be interpreted with caution, it is encour-
aging to find decreasing trends, especially in the proportion
of HBP patients in the ACS population, with a reduction of
nearly 600 people per year, after the implementation of a
major public health measure that was meant to reduce salt
intake.
Even a small reduction in the proportion of HBP in
the ACS population, as the one observed in our study
Fig. 1 Proportion of patients with HBP in the ACS population. Female/male ratio from years 2002 to 2015
Fig. 2 Trends in overall monthly proportion of HBP in ACS patients from January 2002 to December 2015. Dashed line represents the beginning
of 2013, year associated to the estimated decline in trends
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Table 2 Results from the three regressions applied, segmented multiple linear regression model, for the proportion of HBP patients,
and both multiples linear regressions using standard methods for interrupted time series, for the ACS and stroke outcomes
β (CI) t-value p-value
HBP proportion
Overalla
Pre-breakpoint trend (change per month) 0.004 (0.003;0.006) – –
Change in trend (post-breakpoint vs pre-breakpoint) −0.006 – < 0.001
Post-breakpoint trend (change per month) −0.002 (− 0.003;-0.001) – –
Malea
Pre-breakpoint trend (change per month) − 0.003(− 0.022;0.022) – –
Change in trend (post-breakpoint vs pre-breakpoint) − 0.016 – 0.215
Post-breakpoint trend (change per month) −0.019(− 0.061;0.023) – –
Femalea
Pre-breakpoint trend (change per month) −0.003(− 0.028;0.022) – –
Change in trend (post-breakpoint vs pre-breakpoint) − 0.016 – 0.215
Post-breakpoint trend (change per month) −0.018(− 0.052;0.014) – –
Age < 65a
Pre-breakpoint trend (change per month) −0.022(− 0.798;0.754) – –
Change in trend (post-breakpoint vs pre-breakpoint) 0.011 – > 0.05
Post-breakpoint trend (change per month) −0.011(− 0.039;0.017) – –
Age ≥ 65a
Pre-breakpoint trend (change per month) 0.029(−0.017;0.075) – –
Change in trend (post-breakpoint vs pre-breakpoint) −0.018 – > 0.05
Post-breakpoint trend (change per month) 0.011(−0.017;0.039) – –
ACS crude rates (per 100,000 adults)
Overalla
Time of the breakpoint −0.112(− 2.041;1.817) −0.114 0.909
Time of the breakpointa time interaction −0.031(− 0.09;0.036) −0.903 0.368
Malea
Time of the breakpoint 0.289(− 2.269;2.848) 0.222 0.825
Time of the breakpointa time interaction −0.018(− 0.108;0.072) −0.393 0.695
Femalea
Time of the breakpoint −0.497(− 1.927;0.932) −0.682 0.496
Time of the breakpointa time interaction 0.013(−0.034;0.060) 0.560 0.576
Age < 65a
Time of the breakpoint 0.151(−0.723;1.024) 0.338 0.736
Time of the breakpointa time interaction −0.015(− 0.044;0.015) −0.986 0.325
Age ≥ 65a
Time of the breakpoint 0.151(− 5.159;6.721) 0.258 0.7970
Time of the breakpointa time interaction −0.015(− 0.358;0.066) −1.349 0.1792
Stroke crude rates (per 100,000 adults)
Overalla
Time of the breakpoint 0.265(−1.399;1.929) 0.312 0.755
Time of the breakpointa time interaction −0.037(− 0.091;0.016) −1.370 0.172
Malea
Time of the breakpoint 0.900(−0.743;2.543) 1.074 0.284
Time of the breakpointa time interaction −0.022(− 0.074;0.030) −0.822 0.412
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of 555 persons per year achieved through a population-wide
approach, can have huge impacts [22, 23]. This impacts has
effectively slowed down the development of atherosclerosis
in young people, thereby reducing the likelihood of future
epidemics of CVD [24].
The decreasing trend for ACS was observed for women
but not in men, in fact salt intake have been previously
link to higher risk of CV events in women but not in men
[25], more particularly studies have found that women
could benefit more, concerning stroke reduction, from
dietary salt reduction than men [26].
As salt sensitivity is known to be greater in the elderly
we hypothesized that if the salt reduction law could have
some effect it would be greater for the elderly [27, 28]. In
fact our results suggest a decreasing trend for all outcomes
in the older group.
Table 2 Results from the three regressions applied, segmented multiple linear regression model, for the proportion of HBP patients,
and both multiples linear regressions using standard methods for interrupted time series, for the ACS and stroke outcomes
(Continued)
β (CI) t-value p-value
Femalea
Time of the breakpoint 0.999(−1.204;3.202) 0.888 0.376
Time of the breakpointa time interaction −0.047(− 0.121;0.027) −1.244 0.215
Age < 65a
Time of the breakpoint 0.448(−0.261;1.157) 1.238 0.217
Time of the breakpointa time interaction −0.014(− 0.037;0.009) −1.207 0.229
Age ≥ 65a
Time of the breakpoint 2.548(− 5.351;10.446) 0.632 0.528
Time of the breakpointa time interaction −0.238(− 0.502;0.026) −1.764 0.079
Values not presented in the table (−) are not available for the type of regression
β represents the coefficients in the regression
HBP High blood pressure, ACS Acute coronary syndrome, CI confidence interval
aAll models were adjusted for seasonality
Fig. 3 Trends in overall monthly crude rates of CV admissions from January 2002 to December 2016 per 100,000 adults. a) Trends for stroke
crude rates admissions. b) Trends for ACS crude rates admissions. Dashed lines represent the beginning of 2013, year associated to the estimated
decline in trends
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Results from this type of population-wide approach
were seen in the UK, where salt reduction campaigns
showed significant results, achieving a 15% salt reduction
from 2003 to 2011, which translated into about 6000
fewer deaths from CVD, saving about 1.5 billion pounds a
year [8].
The decreasing trends for all of our outcomes was not as
great as we expected, however the fact that the starting of
the decrease takes place after the implementation of these
approaches, and the trend of HBP in ACS patients was
steadily increasing before that, supports our hypothesis
that this approach of reducing salt in bread and making
pre-packed salt labelling mandatory can influence HBP
prevalence in ACS patients as well as CVD trends.
The fact that, salt intake levels have been decreasing in
Portugal to the most recent value of 7.3 g/day in 2016
[14] also supports our hypothesis of the potentially effect
of the regulation applied in the country. Although this
value was obtained by a 24 h dietary recall question-
naire [29], these values were validated against urinary so-
dium excretion for a sub-sample of 100 subjects and the
values were highly correlated.
In addition, BP levels have been declining in the
Portuguese population, from a mean BP of 134.7/
80.5 mmHg in 2003 [30] to a mean BP of 127/
74.6 mmHg in 2012 [10].
Furthermore, several studies showed that bread is one
important source of salt in Portugal [7], and contributes
to about one-sixth of daily salt intake [7]. Results from the
National Food, Nutrition and Physical Activity Survey
suggest most of the salt consumed by the population
comes directly from bread and toast, charcuterie products,
and soups [14]. It was all this evidence that led to the
creation of the regulation to reduce salt in bread to a
minimum of 1.4 g of salt per 100 g of final product [31]
and mandatory labelling for pre-packed products stating
clearly the salt content of the product. Portugal was, thus,
the first western country to create a law for the clear
definition of the quantity of salt contained in bread.
Besides the legislation in 2010, several initiatives have
been carried in Portugal to reduce salt intake, such as:
electronic tools, such as websites included in the National
Program for the Promotion of Healthy Eating, to free
distribution of books and brochures, by the creation of
an animated series, and the creation of the National
Food, Nutrition and Physical Activity Survey, aiming to
collect nationwide data on dietary intake and physical
activity [14].
There is already evidence that reducing salt intake could
reduce BP in the Portuguese population. One community
intervention trial conducted in Portugal demonstrated
that reducing salt intake in an entire village, including
cooking and processed food, led to a significant reduction
in the BP of the population [32].
Policy interventions to reduce national sodium con-
sumption have demonstrated to be highly cost effective in
nearly every country in the world. These interventions
could reduce millions of disability adjusted life years at
low cost and be more cost-effective than pharmacological
interventions [26, 33].
Policy and system changes are critical to reduce HBP in
populations, including legislation and public education
to reduce dietary sodium and food pricing policies, to
support prevention and management of CVD [34].
Alternative public health approaches, such as reducing
salt in processed foods and bread, and labelling of processed
food along with the use of multiple fiscal and educational
policies, have already been proposed by the WHO as the
first-line approach for CVD reduction, when implemented
on a wide scale [24, 34].
In spite of several efforts being made in the country to
reduce salt intake, there is still room for improvement,
namely in food labelling [35], adjusting it to the level of
health literacy in the country. Once the level of health
literacy in Portugal was slightly lower than the rest of
European countries [36], this might have prevented the
population from fully benefiting from the labelling, as
the interpretation of salt content in each food can be
difficult.
Simpler labelling systems already exist in other countries,
such as labels that rely on the use of front-of-pack informa-
tion such as logos with information on the overall healthi-
ness of the food and traffic light and colour coding systems,
which might help citizens make healthier choices. Countries
such as Finland and the UK have already implemented
some of these labelling systems. In Finland, food products
with salt contents below the designated levels display a
low-salt label to emphasise their lower-than-conventional
salt levels [37]. In the UK, a traffic light system to distin-
guish between high, medium, and low salt content in food
products was implemented. These strategies proved to be
efficient in reducing salt intake in the population [38]. The
traffic light labelling system has been proposed by the Por-
tuguese Hypertension Society to help the population choose
products regardless of their level of literacy.
More restrictions are being planned in Portugal to fur-
ther reduce salt intake, such as a taxes on products with
more than 1 g of salt per 100 g of finished product such as:
pre-packaged crackers and biscuits; pre-packaged cereal
flakes and pressed cereals; and pre-packaged, dehydrated
potato chips. A rate of 0.80 Euros per kilogram of finished
product will be applied to these products.
On the other hand, further reduction of salt content in
bread, to a minimum of 1 g per 100 g of final product,
was proposed to be achieved by 2020, with continuous
reductions each year after 2018.
Our study presents encouraging indications suggest-
ing there have been reductions in the proportion of
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hypertensives among ACS patients after 2013, along
with an annual decrease in the rates of ACS and stroke.
Limitations
However, we recognise some limitations of the study.
Like any ecological study, it is not possible to prove
causal relations, i.e. direct association between the initia-
tives to reduce salt implement in the country the reduction
observed in the proportion of hypertensives ACS patients.
However, our methodology was applied, using the same
data to analyse the effects of the smoking ban legislation
on ACS trends, and a significant reduction was found right
after the ban [39].
On the other hand, it might be too soon to notice
great effects from salt reduction on CVD trends.
The fact that until 2013, the trend for the proportion
of hypertensives was continuously increasing, and right
after 2013 a decrease in trend can be observed, suggests
that the lack of statistical significance could result from
the time period being analysed being too short to capture
further reductions.
Moreover, our study has some strengths, such as the fact
that we used two well validated and standardised databases
is a major strength as this allows for an easy comparison
with other international studies mainly those developed in
other European countries. As well as the availability of
information on gender and age, this allowed us to assess
the robustness of our findings among different subgroups.
Also the time series method is preferred over the simpler
pre- and post-proportion comparison method that does
not take the pre-intervention trend into account, and also
allows correction for autocorrelation [40].
Conclusions
In conclusion, the fact that we found decreasing trends
for both HBP in ACS patients and CVD outcomes after
major initiatives to reduce salt intake were implemented
in the country, suggests that this type of approaches,
although hard to measure, can impact the trends of major
public health outcomes. Thus, this research is relevant to
the public health community because it provides an
indication about the impact that a population-wide
approaches can have on CVD risk factors, and CVD trends
themselves. Our results suggest that population-wide
approaches can have an impact on the prevention and
improvement of CVD control, reducing the number of
CVD events and eventually reducing premature death,
morbidity, and disability by CVD. Our study also highlights
the importance of measuring the impact of these types of
initiatives. These findings stress the need for public health
policy in CVD to improve the health of populations
addressing, in the first place, the well identified risk factors
for CVD.
Undoubtedly, more studies are needed to assess the
impact of such measures, not only for other diseases beside
CVD, but also adding more years to the study would allow
analysis of long terms effects of the public health initia-
tives. On the other hand, as more restrictions on salt intake
are being planned in Portugal, in the next years it is very
relevant to assess what is the current panorama and what
further reductions we can expect.
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